.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Novartis
Covington
Boehringer Ingelheim
Fish and Richardson
Healthtrust
Cerilliant
UBS
Mallinckrodt
Argus Health

Generated: December 17, 2017

DrugPatentWatch Database Preview

Claims for Patent: 5,932,622

« Back to Dashboard

Claims for Patent: 5,932,622

Title: Method for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acid
Abstract:A method for modulating non-malignant skin related disorders in a subject has been demonstrated with 9-cis retinoic acid. Wrinkling, acne, keratinization, differentiation and proliferation disorders are treated by administration of 9-cis retinoic acid alone or in a pharmaceutically acceptable carrier to a subject in need thereof.
Inventor(s): Evans; Ronald M. (La Jolla, CA), Mangelsdorf; David J. (Dallas, TX), Heyman; Richard A. (Encinitas, CA), Boehm; Marcus F. (San Diego, CA), Eichele; Gregor (Houston, TX), Thaller; Christina (Houston, TX)
Assignee: The Salk Institute for Biological Studies (La Jolla, CA) Baylor College of Medicine (Houston, TX) Ligand Pharmaceuticals, Inc. (San Diego, CA)
Application Number:08/475,174
Patent Claims: 1. A method for in vivo modulation of a non-malignant skin disorder in a subject, wherein said non-malignant skin disorder is selected from the group consisting of aging, wrinkingling, acne, keratinization, differentiation, and proliferation disorders,

said method comprising administering to said subject an effective amount of 9-cis-retinoic acid or pharmaceutically acceptable carriers containing same.

2. A method for in vivo modulation of the development of benign tumors in the skin of a subject, said method comprising administering to said subject an effective amount of 9-cis-retonic acid or pharmaceutically acceptable carriers containing same.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Queensland Health
Fish and Richardson
Daiichi Sankyo
UBS
Johnson and Johnson
Medtronic
QuintilesIMS
Federal Trade Commission
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot